CJC-1295 vs. Ipamorelin — Clear Comparison
CJC-1295 gives longer growth-hormone release; ipamorelin causes short GH pulses. Together they raise GH but carry safety and regulatory concerns. Short answer: CJC-1295 extends growth-hormone release; ipamorelin triggers quick GH pulses. Many people use CJC-1295 with ipamorelin together to get both effects, but safety and approval are limited. Quick overview A plain snapshot of what each peptide does. CJC-1295 is a long-acting GHRH analog that raises GH and IGF-1 over days. Ipamorelin is a selective ghrelin-receptor agonist that causes short GH pulses. People combine them to get sustained plus pulsed GH signals. How they work? A simple look at the mechanisms. · CJC-1295: It mimics growth-hormone-releasing hormone (GHRH) and binds where GHRH acts, so the body releases more GH for longer periods. This can raise IGF-1, too. · Ipamorelin: It acts on the ghrelin/growth...